Investigation of mechanisms by which BTLA inhibit autoimmunity and development of potential therapeutic applications
Project/Area Number |
21591263
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
膠原病・アレルギー・感染症内科学
|
Research Institution | Chiba University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
NAKAJIMA Hiroshi 千葉大学, 大学院・医学研究院, 教授 (00322024)
HIROSE Kohichi 千葉大学, 医学部附属病院, 講師 (90400887)
HANAOKA Hideki 千葉大学, 医学部附属病院, 講師 (80361426)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | BTLA / 副刺激分子 / 自己免疫疾患 / 免疫寛容 / 樹状細胞 / MRL/lprマウス / ノックアウトマウス / 自然免疫 / NKT細胞 |
Research Abstract |
Recently, we have identified B and T lymphocyte attenuator (BTLA) as a novel inhibitory coreceptor expressed on lymphocytes. In this study, we found that the lack of BTLA exaggerates the systemic autoimmunity in lupus-prone MRL-lpr/lpr mice. In addition, we found that BTLA is also expressed on dendritic cells and serves inhibitory functions in dendritic cells. These results demonstrate that BTLA plays a protective role in autoimmune diseases and also suggest potential therapeutic applications of BTLA.
|
Report
(4 results)
Research Products
(25 results)
-
[Journal Article] A functional polymorphism in B and T lymphocyte attenuator is associated with susceptibility to rheumatoid arthritis2011
Author(s)
Oki M, Watanabe N, Owada T, Oya Y, Ikeda Oki M, Watanabe N, Owada T, Oya Y, IkedaK, Nakajima H, 他3名
-
Journal Title
Clin Dev Immunol
Pages: 305656-305656
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-